Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 5, 1999

View Archived Issues

Company Profile: Cerus

Another series of heterocyclic thrombin inhibitors revealed by Lilly

Novel compounds synthesized at BMS particularly useful for prevention of postsurgical adhesions

CytoTherapeutics granted U.S. patent covering human neural stem cells

Levofloxacin cleared for new indication by FDA

NIH issues grant to Hughes Institute to further development of anti-HIV contraceptives

S-1153: preclinical and preliminary clinical results presented at AIDS congress

New HIV protease inhibitor JE-2147 with promising preclinical profile

Second phase II trial commences for SIB-1508Y

Ophthalmic INS-365 to be developed by Inspire in collaboration with Santen

FDA clears new product for preventing kidney transplant rejection

Angiogene's vascular-targeting agent for solid tumors enters Zeneca's development portfolio

SciClone continues to receive and seek approvals for Zadaxin

JTT-501 improves insulin resistance in two rodent models

Mayo Clinic closes in on gene causing PD and essential tremor

Lilly obtains license for technology expected to broaden indications for Humatrope

Study in ovariectomized monkeys supports potential of zoledronate for osteoporosis

Therapies that improve thymus function for immune reconstitution following HAART